GOG-0225
Closed to Accrual
Protocol Information
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Principal Investigator
David S. Alberts
Status
Closed to Accrual
Open to Accrual
June 18, 2012
Closed to Accrual
August 24, 2018
Disease Site
Gynecologic [GY] Ovarian
Phase
Other
Developmental Therapeutics
No
Primary Objective
To determine if women who are disease free after successfully completing primary and potential consolidation/maintenance, therapy for Stage II-IV ovarian, fallopian tube or primary peritoneal cancer and who are randomized to a healthy lifestyle intervention, will have significantly increased progression free survival compared to similar women who are randomized to a usual care comparison group.
Patient Population
Women who are disease free after successfully completing primary and potential consolidation/maintenance, therapy for Stage II-IV ovarian, fallopian tube or primary peritoneal cancer and who are randomized to a healthy lifestyle intervention and similar women who are randomized to a usual care comparison group.
Target Accrual
1150
- GOG-0225_Protocol_Amendment_9_July_17_2018_Tracked.pdf
- GOG-0225_Protocol_Amendment_9_July_17_2018.pdf
- GOG-0225_Protocol_Amendment_8_tracked_June_8_2018.pdf
- GOG-0225_Protocol_Amendment_8_June_8_2018.pdf
- GOG-0225_Protocol_Amendment_7_March_23_2018_Tracked.pdf
- GOG-0225_Protocol_Amendment_7_March_23_2018.pdf
- 0225_Amendment_6_Feb_19_2016.pdf
- 0225-Amendment-6-Tracked.pdf
- 0225-Amendment-5.pdf
- 0225-Amendment-5-Tracked.pdf
- 0225-Amendment-4.pdf
- 0225-Amendment-4-Tracked.pdf
- 0225-Amendment-3.pdf
- 0225-Amendment-2-Tracked.pdf
- 0225-Amendment-2.pdf
- 0225-Amendment-3-tracked.pdf
- 0225-Amendment-10-tracked.pdf
- 0225-IC-Amendment-5-Tracked.pdf
- 0225-IC-Amendment-6-Tracked.doc
- 0225-IC-Amendment-6.doc
- 0225-IC-Amendmet-5.pdf
- GOG-0225_Consent_Amendment_9_July_17_2018.doc
- GOG-0225_Consent_Amendment_9_July_17_2018_Tracked.doc
- GOG-0225_Informed_Consent_Amendment_7_March_23_2018.docx
- GOG-0225_IC_Amendment_8_tracked_June_8_2018.doc.doc
- GOG-0225_IC_Amendment_8_June_8_2018.doc
- GOG-0225_Informed_Consent_Amendment_7_March_23_2018_Tracked.docx
- 0225-Appendix-1-FIGO.pdf
- 0225-LIVES-brochure.pdf
- 0225-Memo-d2m-addition.pdf
- 0225-Memo-LIVES_Flyer.pdf
- 0225-Memo-MD-QuickRefernce.pdf
- 0225-Whole-Blood-Shipping-Change.pdf
- 0225-Memo-Suspension-of-Specimen-Submission-121913.pdf
- 0225-Amendment-10-Memo.pdf
- GOG-0225-Appendix-II-Spec-Procedures-tracked.pdf
- GOG-0225-Appendix-II-Spec-Procedures.pdf